There was no significant differences in tumour overall response rates (partial + complete response) between EGFR sensitizing mutations and wild type groups (RR 1.17, 95% confidence interval (CI) 0.99 to 1.37, P = 0.06; Figure 2). Here, EGFR is linked to neoplasm.